A qualitative transcriptional signature of recurrence risk for stages II-III gastric cancer patients after surgical resection
- PMID: 33565610
- DOI: 10.1111/jgh.15439
A qualitative transcriptional signature of recurrence risk for stages II-III gastric cancer patients after surgical resection
Abstract
Background and aim: Metastasis is the leading cause of recurrence in gastric cancer. However, the imaging techniques and pathological examinations for tumor metastasis have a high false-positive rate or a high false-negative rate, and many proposed that metastasis-related molecular biomarkers can hardly be validated in independent datasets.
Methods: We propose to use significantly stable gene pairs with reversal relative expression orderings (REOs) between non-metastasis and metastasis gastric cancer samples as the metastasis-related gene pairs. Based on the REOs of these gene pairs, we developed a qualitative transcriptional signature for predicting the recurrence risk of stages II-III gastric cancer patients after surgical resection.
Results: A REOs-based signature, consisting of 19 gene pairs (19-GPS), was selected from 77 stages II-III gastric cancer patients and validated in two independent datasets. Samples in the high-risk group had shorter disease-free survival time and overall survival time than those in the low-risk group. Differentially expressed genes (DEGs) between the high- and low-risk groups classified by 19-GPS were highly reproducible comparing with those between lymph node metastasis and lymph node non-metastasis groups. Functional enrichment analysis showed that these DEGs were significantly enriched in metastasis-related pathways, such as PI3K-Akt and Rap1 signaling pathways. The multi-omics analyses suggested that the epigenetic and genomic features might cause transcriptional differences between two subgroups, which help to characterize the mechanism of gastric cancer metastasis.
Conclusions: The signature could robustly identify patients at high recurrence risk after resection surgery, and the multi-omics analyses might aid in revealing the metastasis-related characteristics of gastric cancer.
Keywords: gastric cancer; multi-omics analysis; recurrence risk; relative expression orderings; transcriptional signature.
© 2021 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.
Similar articles
-
A qualitative transcriptional signature for predicting the biochemical recurrence risk of prostate cancer patients after radical prostatectomy.Prostate. 2020 Apr;80(5):376-387. doi: 10.1002/pros.23952. Epub 2020 Jan 21. Prostate. 2020. PMID: 31961962 Free PMC article.
-
A Qualitative Transcriptional Signature for Predicting Recurrence Risk of Stage I-III Bladder Cancer Patients After Surgical Resection.Front Oncol. 2019 Jul 10;9:629. doi: 10.3389/fonc.2019.00629. eCollection 2019. Front Oncol. 2019. PMID: 31355144 Free PMC article.
-
An individualized prognostic signature and multi‑omics distinction for early stage hepatocellular carcinoma patients with surgical resection.Oncotarget. 2016 Apr 26;7(17):24097-110. doi: 10.18632/oncotarget.8212. Oncotarget. 2016. PMID: 27006471 Free PMC article.
-
[Clinical significance and efficacy of conversion surgery for patients with stage IV gastric cancer].Zhonghua Wei Chang Wai Ke Za Zhi. 2018 Oct 25;21(10):1087-1092. Zhonghua Wei Chang Wai Ke Za Zhi. 2018. PMID: 30370504 Review. Chinese.
-
Updated evaluation of endoscopic submucosal dissection versus surgery for early gastric cancer: A systematic review and meta-analysis.Int J Surg. 2020 Jan;73:28-41. doi: 10.1016/j.ijsu.2019.11.027. Epub 2019 Nov 26. Int J Surg. 2020. PMID: 31783166
References
-
- Ajani JA, D'Amico TA, Almhanna K et al. Gastric Cancer, Version 3.2016, NCCN clinical practice guidelines in oncology. J. Natl. Compr. Canc. Netw. 2016; 14: 1286-1312.
-
- Cuschieri A, Weeden S, Fielding J et al. Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group. Br. J. Cancer 1999; 79: 1522-1530.
-
- Arigami T, Uenosono Y, Yanagita S et al. Clinical significance of lymph node micrometastasis in gastric cancer. Ann. Surg. Oncol. 2013; 20: 515-521.
-
- Zeng YJ, Zhang CD, Dai DQ. Impact of lymph node micrometastasis on gastric carcinoma prognosis: a meta-analysis. World J. Gastroenterol. 2015; 21: 1628-1635.
-
- Berlth F, Chon SH, Chevallay M, Jung MK, Mönig SP. Preoperative staging of nodal status in gastric cancer. Transl. Gastroenterol. Hepatol. 2017; 2: 8.
MeSH terms
Grants and funding
- 2020J01600/Natural Science Foundation of Fujian Province
- 2019-WJ-32/Joint Research Program of Health and Education in Fujian Province
- 2018Y9065/Innovation of Science and Technology of Fujian Province
- 81602738/National Natural Science Foundation of China
- 81872396/National Natural Science Foundation of China
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical